239 related articles for article (PubMed ID: 22847545)
1. Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.
Chaitanya S; Lavania M; Turankar RP; Karri SR; Sengupta U
J Clin Immunol; 2012 Dec; 32(6):1415-20. PubMed ID: 22847545
[TBL] [Abstract][Full Text] [Related]
2. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
[TBL] [Abstract][Full Text] [Related]
3. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
[TBL] [Abstract][Full Text] [Related]
5. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
6. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
7. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
[TBL] [Abstract][Full Text] [Related]
8. Cortisol and proinflammatory cytokine profiles in type 1 (reversal) reactions of leprosy.
Chaitanya VS; Lavania M; Nigam A; Turankar RP; Singh I; Horo I; Sengupta U; Jadhav RS
Immunol Lett; 2013; 156(1-2):159-67. PubMed ID: 24189521
[TBL] [Abstract][Full Text] [Related]
9. Reaction in leprosy: acute phase reactant response during and after remission.
Sehgal VN; Bhattacharya SN; Shah Y; Sharma VK; Gupta CK
Int J Dermatol; 1992 Sep; 31(9):632-4. PubMed ID: 1459760
[TBL] [Abstract][Full Text] [Related]
10. Solubilization of preformed immune complexes in sera of patients with type 1 and type 2 lepra reactions.
Chakrabarty AK; Kashyap A; Sehgal VN; Saha K
Int J Lepr Other Mycobact Dis; 1988 Dec; 56(4):559-65. PubMed ID: 3221112
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
12. Experimental borderline lepromatous leprosy with intraneural erythema nodosum leprosum in a mangabey monkey (Cercocebus atys).
Baskin GB; Gormus BJ; Xu K; Martin LN; Wolf RH; Cantrell C; Pezeshkpour GH; Walsh GP; Malaty R; Meyers WM
Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):618-23. PubMed ID: 1802944
[TBL] [Abstract][Full Text] [Related]
13. Involvement of TNF-Producing CD8
Silva PHL; Santos LN; Mendes MA; Nery JAC; Sarno EN; Esquenazi D
Am J Trop Med Hyg; 2019 Feb; 100(2):377-385. PubMed ID: 30652669
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
15. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
Suryawati N; Saputra H
Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
[TBL] [Abstract][Full Text] [Related]
16. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
George J; Bhatia VN; Balakrishnan S; Ramu G
Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
[TBL] [Abstract][Full Text] [Related]
17. Production of transforming growth factor-beta 1 (TGF-beta1) by blood monocytes from patients with different clinical forms of leprosy.
Goulart IM; Mineo JR; Foss NT
Clin Exp Immunol; 2000 Dec; 122(3):330-4. PubMed ID: 11122237
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
Sarno EN; Grau GE; Vieira LM; Nery JA
Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
[TBL] [Abstract][Full Text] [Related]
19. Current views on reactions in leprosy.
Naafs B
Indian J Lepr; 2000; 72(1):97-122. PubMed ID: 10935190
[No Abstract] [Full Text] [Related]
20. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein.
Singh S; Narayanan NP; Jenner PJ; Ramu G; Colston MJ; Prasad HK; Nath I
Infect Immun; 1994 Jan; 62(1):86-90. PubMed ID: 7505263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
